Works matching DE "HEPATITIS D"


Results: 305
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Lonafarnib: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 2, p. 283, doi. 10.1007/s40265-020-01464-z
    By:
    • Dhillon, Sohita
    Publication type:
    Article
    12

    Bulevirtide: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 15, p. 1601, doi. 10.1007/s40265-020-01400-1
    By:
    • Kang, Connie;
    • Syed, Yahiya Y.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    "Real world" efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy.

    Published in:
    HIV Medicine, 2023, v. 24, n. 10, p. 1075, doi. 10.1111/hiv.13518
    By:
    • Visco Comandini, Ubaldo;
    • De Santis, Emanuela;
    • De Maria, Francesco;
    • Lionetti, Raffaella;
    • Taibi, Chiara;
    • Montalbano, Marzia;
    • Rianda, Alessia;
    • Piccolo, Paola;
    • De Ponte, Chiara;
    • Mazzotta, Stefania;
    • Caioli, Alessandro;
    • Garbuglia, Anna Rosa;
    • Maggi, Fabrizio;
    • D'Offizi, Gianpiero
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    HERACLIS‐TAF: a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 702, doi. 10.1111/apt.17093
    By:
    • Papatheodoridis, George V.;
    • Mimidis, Kostas;
    • Manolakopoulos, Spilios;
    • Gatselis, Nikolaos;
    • Goulis, John;
    • Kapatais, Andreas;
    • Manesis, Emanuel;
    • Vasiliadis, Themistoklis;
    • Triantos, Christos;
    • Samonakis, Dimitrios;
    • Sevastianos, Vasilios;
    • Karatapanis, Stelios;
    • Elefsiniotis, Ioannis;
    • Deutsch, Melanie;
    • Mylopoulou, Theodora;
    • Papatheodoridi, Margarita;
    • Kranidioti, Hariklia;
    • Agorastou, Polyxeni;
    • Karaoulani, Theofani;
    • Kyriazidou, Anastasia
    Publication type:
    Article
    32

    Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a "real world" study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 144, doi. 10.1111/apt.16945
    By:
    • Jachs, Mathias;
    • Schwarz, Caroline;
    • Panzer, Marlene;
    • Binter, Teresa;
    • Aberle, Stephan W.;
    • Hartl, Lukas;
    • Dax, Kristina;
    • Aigner, Elmar;
    • Stättermayer, Albert F.;
    • Munda, Petra;
    • Graziadei, Ivo;
    • Holzmann, Heidemarie;
    • Trauner, Michael;
    • Zoller, Heinz;
    • Gschwantler, Michael;
    • Mandorfer, Mattias;
    • Reiberger, Thomas;
    • Ferenci, Peter
    Publication type:
    Article
    33

    Corrigendum.

    Published in:
    2022
    Publication type:
    Correction Notice
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    What Is Hepatitis D Infection?

    Published in:
    JAMA: Journal of the American Medical Association, 2024, v. 331, n. 18, p. 1602, doi. 10.1001/jama.2024.1317
    By:
    • Voelker, Rebecca
    Publication type:
    Article
    46
    47

    Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP).

    Published in:
    PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0117152
    By:
    • Veloso Alves Pereira, Isabel;
    • Buchmann, Bettina;
    • Sandmann, Lisa;
    • Sprinzl, Kathrin;
    • Schlaphoff, Verena;
    • Döhner, Katinka;
    • Vondran, Florian;
    • Sarrazin, Christoph;
    • Manns, Michael P.;
    • Pinto Marques Souza de Oliveira, Cláudia;
    • Sodeik, Beate;
    • Ciesek, Sandra;
    • von Hahn, Thomas
    Publication type:
    Article
    48
    49
    50